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A scoping review of pre-hospital
technology to assist ambulance personnel
with patient diagnosis or stratification
during the emergency assessment of
suspected stroke
Hannah A Lumley1*, Darren Flynn2, Lisa Shaw1, Graham McClelland1,3, Gary A Ford4, Phil M White1,5 and
Christopher I Price1,6
Abstract
Background: Pre-hospital identification of key subgroups within the suspected stroke population could reduce
delays to emergency treatment. We aimed to identify and describe technology with existing proof of concept for
diagnosis or stratification of patients in the pre-hospital setting.
Methods: A systematic electronic search of published literature (from 01/01/2000 to 06/06/2019) was conducted in
five bibliographic databases. Two reviewers independently assessed eligibility of studies or study protocols
describing diagnostic/stratification tests (portable imaging/biomarkers) or technology facilitating diagnosis/
stratification (telemedicine) used by ambulance personnel during the assessment of suspected stroke. Eligible
descriptions required use of tests or technology during the actual assessment of suspected stroke to provide
information directly to ambulance personnel in the pre-hospital setting. Due to study, intervention and setting
heterogeneity there was no attempt at meta-analysis.
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Results: 2887 articles were screened for eligibility, 19 of which were retained. Blood biomarker studies (n = 2) were
protocols of prospective diagnostic accuracy studies, one examining purines and the other a panel of known and
novel biomarkers for identifying stroke sub-types (versus mimic). No data were yet available on diagnostic accuracy
or patient health outcomes. Portable imaging studies (n = 2) reported that an infrared screening device for
detecting haemorrhages yielded moderate sensitivity and poor specificity in a small study, whilst a dry-EEG study to
detect large vessel occlusion in ischaemic stroke has not yet reported results. Fifteen evaluations of pre-hospital
telemedicine were identified (12 observational and 3 controlled comparisons) which all involved transmission of
stroke assessment data from the pre-hospital setting to the hospital. Diagnosis was generally comparable with
hospital diagnosis and most telemedicine systems reduced time-to-treatment; however, it is unknown whether this
time saving translated into more favourable clinical outcomes. Telemedicine systems were deemed acceptable by
clinicians.
Conclusions: Pre-hospital technologies to identify clinically important subgroups amongst the suspected stroke
population are in development but insufficient evidence precludes recommendations about routine use in the pre-
hospital setting. Multi-centre diagnostic accuracy studies and clinical utility trials combining promising technologies
are warranted.
Keywords: Stroke, Pre-hospital, Stratification, Diagnosis, Technology, Biomarkers, Imaging, Telemedicine, Ambulance,
Paramedic
Introduction
Stroke is a medical emergency responsible for a high
global burden of mortality and disability, but the outlook
is improved by rapid treatment of specific subgroups;
such as intravenous thrombolysis for selected ischaemic
stroke presentations [1, 2] and mechanical thrombec-
tomy (MT) for large vessel occlusion (LVO) [3]. Due to
the increasing centralisation of acute stroke care at spe-
cialist facilities [4], early identification and stratification
is needed to ensure prompt arrival at the correct hos-
pital for efficient treatment.
For most individuals with acute stroke, the first health-
care contact is a paramedic. However, accurate identifi-
cation is challenging in the pre-hospital setting due to
heterogeneous clinical presentations, time pressure and
an absence of simple diagnostic technology. Currently,
ambulance personnel use symptom checklists, such as
the Face Arm Speech Test (FAST) [5], which have
moderate-to-good sensitivity but lower levels of specifi-
city, such that 30–50% of suspected stroke patients later
receive an alternative ‘mimic’ diagnosis [5–7]. Once in
hospital, stroke and the aetiological sub-type are con-
firmed via specialist review and brain imaging (com-
puted tomography (CT) and/or magnetic resonance
imaging (MRI)) so that mimic cases are excluded and
appropriate treatments can be given. In some settings
this assessment has been taken to patients using highly
equipped ‘mobile stroke unit’ ambulances, with evidence
that thrombolysis can be delivered more rapidly [8, 9].
However, current models require a stroke specialist to
be present in the vehicle which is not the standard ap-
proach for emergency care provision in many healthcare
systems.
Currently, key stroke subgroups cannot be identified
until after hospital arrival. There is no clinical assess-
ment process which can accurately differentiate between
ischaemic and haemorrhagic stroke, and mimics. Now
there is overwhelming evidence favouring MT treatment
for patients with more severe stroke due to LVO, this
group (approximately 10% [10]) should be found as early
as possible for direction to those centres able to provide
treatment. Symptom severity scores have been developed
to assist pre-hospital LVO recognition, but primary evi-
dence of impact on outcome is lacking and accuracy is
reduced by mimic, haemorrhagic and non-LVO presen-
tations exhibiting severe symptoms [11, 12].
Pre-hospital assessment based upon symptom check-
lists alone creates substantial inefficiencies for stroke pa-
tients (treatment delays), mimics (displacement to
specialist units) and services (additional demands on re-
sources). However, improvement in early stratification/
diagnosis of stroke and LVO/ICH subgroups may be
possible with emerging technologies which are deploy-
able in standard ambulances [13]. Many are still at early
stages of development and will require evaluation of
feasibility and resource impact relative to their ability to
differentiate, individually or in combination, between
key subgroups during the first few hours after symptom
onset [14].
Aim
The aim of this scoping review was to identify, categor-
ise and report the capability of technologies where proof
of concept exists for diagnosis and/or stratification of
suspected stroke when used by ambulance personnel in
the pre-hospital setting.
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Objectives
1. Describe and classify technologies intended to en-
hance pre-hospital diagnosis of stroke, and/or stratifica-
tion of suspected stroke, based upon published studies
and protocols.
2. Describe evidence for proof of concept and/or feasi-
bility and/or accuracy of the technology according to its
stage of development.
3. Describe the impact of the technology on patient
care processes or outcomes if data are available.
Review methods
Methods using standard guidelines [15] have already
been described in detail in an online protocol
(CRD42018087611) [16].
Search strategy
Following exploratory searches, with reference to the
scoping review question and in collaboration with an in-
formation scientist, a systematic search strategy combin-
ing MeSH/Web of Science categories and keywords/
topic searches was developed and applied to Medline,
PubMed, Embase and Web of Science up to 06/06/2019.
Hand searching of reference lists and citation searches
of included studies were undertaken. Searches were also
conducted in online trial registries to identify currently
unpublished registered trials on candidate technologies
not detected in the literature search. The search strat-
egies are found in 'Additional file 1: Appendix 1'. Papers
published before the year 2000 were excluded as there
was little emphasis on stroke-specific assessment tech-
nologies prior to expansion of the evidence supporting
intravenous thrombolysis.
Conference abstracts published after 2013 were identi-
fied by applying the search strategy to the databases,
with searches limited to ‘conference abstracts’. Grey lit-
erature was identified from contact with clinical pre-
hospital care content experts. This was done to identify
emerging technologies.
Review criteria
Primary quantitative, qualitative or mixed methods re-
search studies and protocols, including feasibility and
pilot studies, with abstracts published in English from
any country were eligible for inclusion.
Eligible articles had to describe completed studies or
protocols which met the following criteria:
1. (i) Direct diagnostic technologies (e.g. biomarkers)
and/or (ii) adjunctive technology to facilitate stratifica-
tion (e.g. telemedicine requiring equipment which isn’t
routinely present in standard ambulances).
2. Application to suspected stroke patients during clin-
ical care.
3. Use by ambulance personnel including paramedics,
emergency medical technicians or other clinicians rou-
tinely providing pre-hospital care in specific countries,
e.g. EMS physicians in Germany [17, 18].
4. How the result would be available to EMS clinicians
in the pre-hospital setting (prior to hospital admission).
5. Technology at any stage of development as long as
it was (or protocols where it is planned to be) applied
during ambulance care of suspected stroke.
Ambulance-based studies were excluded if the tech-
nology would not be transferrable to standard ambu-
lances without them becoming specialised vehicles (e.g.
Mobile Stroke Units which include Computed Tomog-
raphy (CT) and a Point of Care lab). Reports which de-
scribed paper-based algorithms, clinical rules and
clinical scales, studies involving medical personnel not
routinely present in the pre-hospital setting, hospital-
based studies, studies focused on paramedic training and
studies which did not exclusively include populations
with suspected stroke were also excluded.
Study selection
Two reviewers (HL and DF) independently assessed ti-
tles/abstracts (stage 1). The same two reviewers inde-
pendently assessed full texts of retained studies for their
conformity to the inclusion criteria using a study selec-
tion form. Disagreements at the second stage were re-
solved via discussion or adjudicated by a third reviewer
(CP).
Data extraction
Data were independently extracted by two reviewers (HL
and DF), with discrepancies solved via discussion or ad-
judication (CP). A data extraction form captured de-
tailed information on studies and technologies
(Additional file 1: Appendix 2). As no adequate frame-
work to evaluate diagnostic technology studies existed
for this purpose, a modified version of the TIDieR
framework [19] was used to standardise descriptions.
This included generic study information (e.g. authors;
publication year, country, purpose [diagnostic and/or fa-
cilitation of care], research design and key findings) and
detailed information about the technologies. As the
scope of the review was worldwide, we did not use the
European Union CE mark guidance on physical invasive-
ness, and a simpler classification system was used [20]:
invasive (penetration/breaking of the skin or entry into a
body cavity); minimally invasive (indirect observation of
internal areas of the body); and non-invasive (no pene-
tration or breaking of the skin). The stage of develop-
ment was recorded as alpha (initial prototype stage),
beta (later iteration of the prototype, feature complete
but not finalised) or gamma (finalised product available
for wider use) [21].
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Data synthesis
As this was a scoping review, there was no a-priori plan
for data meta-analysis. Extracted information was used
to develop a taxonomy describing direct or facilitative
stratification technologies according to their mode of ac-
tion. Where reported, data on true/false positives and
negatives were used to calculate sensitivity and specifi-
city values. Studies were classified according to study de-
sign to inform recommendations based upon strength of
evidence.
Results
A total of 4870 (2886 after deduplication) studies were
identified via the search strategy (Fig. 1). One study was
identified via citation searches. 94 potentially eligible ar-
ticles were retained following initial screening. After
obtaining and reviewing full texts (or abstracts where full
texts were not available), 75 studies were excluded with
reasons detailed in Fig. 1. In total, 19 studies were in-
cluded, 8 of which were full text articles, 7 conference
abstracts and 4 published protocols.
Description of included studies
Technologies employed by included studies [22–40]
were best described using three categories: blood bio-
markers [22, 23]; pre-hospital imaging [24, 25] and mo-
bile telemedicine/telestroke (including transfer of audio
and/or visual information or relevant data) [26–40].
These are summarised in Table 1.
Most studies were conducted in the USA [24, 26, 27,
34–39], followed by Germany [28–30] and Belgium [31–
33]. One study was conducted in each of the following
countries: UK [23], Finland [22], Netherlands [25] and
Sweden [40].
Blood biomarkers
We identified protocols for two currently active, large
pre-hospital studies of blood biomarker technologies
which are both prospective diagnostic accuracy designs
[22, 23], summarised in Table 2.
The Helsinki Ultra-acute Stroke Biomarker Study [22]
is an early stage, single-centre study aiming to establish
diagnostic and predictive biomarkers for potential IVT
candidates. The specific aims are to (i) identify ischemic
stroke, transient ischemic attack, intracerebral haemor-
rhage and stroke mimics; (ii) identify patients not
responding to IVT; (iii) identify patients with increased
chance of IVT-related complications; and (iv) predict
90-day patient health outcomes using the modified Ran-
kin Scale (mRS). The study will evaluate known stroke
biomarkers, e.g. Glial Fibrillary Acidic Protein (GFAP)
and NR2 peptide, and explore novel markers (during a
discovery phase) via blood samples taken by EMS clini-
cians during transit. This study has yet to report on
Fig. 1 Flow diagram summarising the process used to identify studies
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primary outcomes, although a precursor study [41] has
reported the feasibility of implementing pre-hospital
EMS biomarker sampling using a cannula adapter tech-
nique. It is not clear how EMS clinicians would obtain a
result on scene in future (e.g. a point of care assay sys-
tem) even if the panel is of value.
Purines for Rapid Identification of Stroke Mimics
(PRISM) [23] is an early stage, multi-centre study aiming
to assess the diagnostic accuracy of whole blood purine
concentration using capillary blood sampling performed
by trained EMS clinicians within 4 h of stroke symptom
onset. The goal is to differentiate between stroke and
stroke mimics, with a hospital sub-study investigating
LVO. The point-of-care SMARTChip system, a hand-
held reader and disposable biosensor, developed by Sar-
issa Biomedical Ltd. in the UK, measures purines in a
finger-prick blood sample. Purines are a by-product of
cellular metabolism which accumulate rapidly during
hypoxia (as occurs in stroke) and can be reliably de-
tected in systemic arterial blood [42]. Results can be ob-
tained within 3–5min and paramedics require training
to use this technology [43]. There is currently no pub-
lished diagnostic accuracy or patient outcome data, how-
ever the technology is at a late stage of development
which would facilitate deployment if of value. Neither
biomarker protocol commented on the potential cost of
the technologies.
Pre-hospital imaging
We identified two studies of non-invasive pre-hospital
imaging technology [24, 25]. These are summarised in
Table 3. EEG is included here as ‘imaging’ since the
intention is to produce information which correlates
anatomically with cerebral tissue injury. From a study
design perspective, these are prospective diagnostic ac-
curacy studies.
Our review identified one small, single-centre study
reporting on use of a handheld Infrared screening device
in the pre-hospital setting in the USA by device-trained
EMS clinicians during transit [24]. The stage of develop-
ment was not reported. The purpose of the device was
to discern between stroke types by detecting changes in
blood flow. The authors found evidence that contrale-
sional increases in blood flow indicate LVO. The device
was compared with hospital-based CT on its ability to
detect haemorrhagic stroke in 46 suspected stroke pa-
tients; 7 of these 46 patients had CT-confirmed haemor-
rhagic stroke. True and false positive/negative results are
shown in Table 3; diagnostic accuracy was extrapolated
from these figures. For haemorrhage versus mimic, sen-
sitivity and specificity within the study population were
71 and 40% respectively. Sensitivity and specificity for
haemorrhage versus ischaemia were 71 and 43% respect-
ively. Although all haemorrhagic strokes were identified
by the device, the poor specificity may limit clinical use.
Paramedics considered the scan too long for stroke pa-
tients and consequent speeding up of the patient scan
time increased false positives. Faster ambulance speed
also increased false positive rates, and the device was dif-
ficult to use reliably with patients unable to lie still.
There was no impact on destination decisions or re-
ported change in patient outcomes.
‘Dry’ electrode cap Electroencephalography (EEG) will
be used in the ELECTRA-STROKE study [25], which is
a large, active multi-centre study in the Netherlands,
aiming to develop and validate an algorithm for auto-
mated signal analysis to detect anterior circulation LVO
in suspected ischaemic stroke patients in the pre-
hospital setting. The technology is fully developed; how-
ever, development of the algorithm is in early stages.
The rationale for this study is underpinned by evidence
that delta activity is associated with lesion location on
cerebral imaging [44]. Omitting the preparation time for
‘wet’ EEG may enable even inexperienced EMS clinicians
to undertake a measurement within 5 min. Training re-
quirements were not reported. Across 4 phases, algo-
rithms will be iteratively tested and developed to
maximise diagnostic accuracy using the CE-marked
Waveguard™ dry electrode cap and the eego™ amplifier.
The algorithm will be validated in the ambulance in a
large multi-centre study. The EEG results will only be
analysed in hospital so destination choice will not be
assessed. It is not reported whether clinical outcomes
will be assessed. Expected primary outcome completion
was December 2019.
There are no data available on costs, EMS clinician de-
cisions regarding hospital destination (stroke-specialist
versus non-stroke specialist centre), impact on treatment
or patient outcomes for either pre-hospital imaging
device.
Mobile telemedicine
We identified 12 mobile telemedicine technologies re-
ported across 15 studies [26–40]. Descriptions are sum-
marised in Table 4. The outcomes are summarised in
Table 5. Eleven studies were single-centre [26, 27, 30–
33, 35–38, 40], one of which was large [30], and four
were moderate-to-large multi-centre studies [28, 29, 34,
39]. From a design perspective, this included: develop-
ment and pilot testing (n = 2), feasibility and pilot testing
(n = 3), mixed methods pilot test (n = 1), retrospective
before and after (n = 1), prospective cohort (n = 4), a
prospective non-randomised controlled trial (n = 1),
protocol: single-centre RCT (n = 1), single-centre RCT
(n = 1).
All telemedicine systems included video and audio
components, with exception of Stroke Angel in which
stroke screening information was collected and
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transferred from the ambulance to hospital. Earlier stud-
ies [26–30] utilised technology with lower resolution
and slower transmission speeds than later studies [31–
40] employing contemporary technology such as high
definition, bi-directional video communication and 4G
networks. Systems were either purpose-built or adapted
from commercially available technology (e.g. tablet PCs).
Most telemedicine systems were in the Beta stage of de-
velopment, with exception of three Gamma stage sys-
tems [30, 33, 34].
The need for EMS clinician training on use of tele-
stroke systems was reported for all but two studies [35,
39]. EMS clinicians were predominately paramedics,
with three studies employing EMS nurses (equivalent to
paramedics in these countries) [31, 33, 40] and one [28]
EMS physicians and paramedics (with the aim of obviat-
ing the need for EMS physicians).
Costs were rarely reported, limiting comparison be-
tween studies. Where reported [26, 27, 34–36], costs are
based on year of publication prices (converted costs
were calculated using historical exchange rates but not
adjusted for inflation). None of the studies reported on
the full range of costs required to implement telestroke
(training, unit, operating and maintenance).
A variety of existing and commonly used pre-hospital
and hospital-based stroke screening scales were used in
conjunction with the telestroke systems (Table 5). Three
studies evaluated and used a bespoke telemedicine scale.
A 14-item stroke history checklist was developed by ex-
perts based on published checklists and recommenda-
tions and evaluated for use in conjunction with the
‘peeq-box’ system [28]. The PreSSUB I and II studies
[31, 32] developed and evaluated the Unassisted Tele-
stroke Scale; included items were based on existing
stroke scales and evaluation of their appropriateness by
experts [45, 46].
Data on diagnostic accuracy of telestroke systems were
reported in five studies [28, 29, 31, 34, 35]. Pre-hospital
stroke diagnosis (versus other neurological/non-neuro-
logical diagnoses) using the ‘peeq-box’ telestroke system
was comparable to standard EMS transport and hospital
confirmed diagnoses of stroke [28]. The Stroke Angel
telestroke system, utilising the Los Angeles Pre-hospital
Stroke Screen, had only moderate sensitivity (66%) and
specificity (62%) for a diagnosis of stroke in the pre-
hospital setting [29]. The PreSSUB I study [31] reported
an equivalent rate of stroke diagnosis between telestroke
and hospital-based clinical assessments (80 and 83% re-
spectively). The InTouch Express telestroke system,
using the Cincinnati Pre-hospital Stroke Scale, had
equivalent rates of true/false positives for stroke diagno-
sis compared with standard EMS transport [34]. Finally,
a smartphone telestroke system with encrypted software
using the National Institute of Health Stroke Scale
(NIHSS) reported ‘high’ intra-rater reliability with
hospital-based NIHSS assessment [35].
Eleven of 15 studies [26–29, 31–36, 40] evaluated ac-
ceptability/usability of telestroke systems from the per-
spective of EMS clinicians and remote physicians using
mixed methods. Results were positive, with studies
reporting only minor issues related to connectivity [28,
34] and high levels of satisfaction with systems [26, 27,
29, 31, 33–36], image quality, reliability, usability or per-
ceived safety [26–29, 33–35, 40]. One study reported
only 25% of EMS nurses believed telestroke could im-
prove assessments and reduce time-to-treatment due to
concerns about clinician ability to use systems and inte-
gration into standard care processes [40]. Robust data
on patient acceptance was not reported.
Time metrics were reported for 11 of 15 telestroke
studies [28–34, 36–39]. Duration of telestroke consult-
ation was reported in three [31, 34, 36]. PreSSUB I [31]
consultations were 9 min (IQR 8–13 min). InTouch
Xpress [34] consultations were 7.3 and 4.7 min (mean)
for thrombolytic and non-thrombolytic patients respect-
ively. Mean duration of NIHSS via the HipaaBridge sys-
tem was 7.6 min [36].
With the Stroke Angel system, which allows transfer
of relevant data to remote clinicians, travel time reduced
by 4 min versus standard EMS transport [29]. Call-to-
door time increased (2 min) and call-to-scene time
matched standard care. The In-Touch Xpress study
assessed onset-to-scene time [34] with a non-significant
decrease of 18.9 min. Where evaluated, there were no
significant differences in time-on-scene [28–30] and
scene-to-door time [28, 34] between telestroke and
standard EMS transport. PreSSUB II was the only study
to assess Call-to-CT time [33], reporting a significant
mean reduction of 36.4 min (95% CI = 17.5 to 55.3) with
telestroke. Door-to-CT time was improved in four stud-
ies [28–30, 37] ranging from 12min [30] to 24min [29].
One study utilising IPads [37] reported significantly re-
duced door-to-CT start (12 min) and result (13 min).
Four studies reported improved door-to-needle times
[29, 34, 38, 39], two of which statistically significantly
[34, 39], ranging from 13min (InTouch Xpress versus
standard EMS transport) [34] to 26min (REACHOUT
versus hospital-based telemedicine) [39]. InTouch
Xpress telestroke significantly decreased onset-to-needle
time (32 min) [34].
Excluding one study, where suspected stroke patients
were taken directly to the nearest specialist centre [35],
telestroke studies did not assess impact on EMS clinician
decisions as a function of hospital destination (stroke-
specialist centre versus non-specialist centre). Impact on
IVT rates were assessed in four studies [28–30, 38]; two
reported non-significant differences versus standard
EMS transport (‘peeq-box’ [28] and Field-Telestroke
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[38]). Compared with standard EMS transport, the
Stroke Angel system elicited significant increases in IVT,
with 7% [30] and 5% [29] increases over 9 and 3-year pe-
riods respectively. However, neither study adjusted for
concurrent increases in the thrombolysis rate. PreSSUB
II [33] has yet to report on this.
Few data are available on patient safety outcomes.
Stroke Angel [29] reported a 1.5% rate of symptomatic
intracerebral bleeding and 11% mortality rate with use of
the system. However, a-priori rates were not reported.
PreSSUB II [33] reported no telestroke-related adverse
events and equivalent mortality outcomes as with stand-
ard EMS transport. The InTouch Xpress [34] telestroke
system also had equivalent mortality (zero), but a lower
complication rate (1 vs 5 respectively), compared with
the standard EMS transport group. None of the tele-
stroke studies reported on patients’ functional health
outcomes, although PreSSUB II [33] plans to.
Discussion
Three categories of pre-hospital technologies, with
intended use by EMS clinicians to facilitate stroke care,
were identified: two direct diagnosis methods (bio-
markers and pre-hospital imaging) and one adjunctive
technology to facilitate stratification (mobile telemedi-
cine/telestroke). Although telemedicine systems have
been in development for some years and are relatively
mature, there was little robust evidence of impact on pa-
tient outcomes. Biomarker and other diagnostic tech-
nologies are at much earlier stages of development.
Blood sampling for biomarkers in the pre-hospital set-
ting appears feasible [41]; however, there is currently no
published evidence on diagnostic accuracy and patient
outcomes for the studies identified: Helsinki Ultra-acute
Stroke Biomarker Study [22] and PRISM [23]. The
Helsinki study examines GFAP which appears promising
for identifying haemorrhage at an early time point [47–
49]; however, this biomarker may not be robust and, as
it does not identify small haemorrhages with the same
performance as large ones, many not be useful to inform
IVT decisions [50]. The other Helsinki biomarker, NR2
peptide, has potential for diagnosing ischaemia but data
within the first 6 h is limited [51, 52]. The role of add-
itional biomarkers may be crucial. There is evidence
supporting the measurement of purines as an indicator
of cerebral ischaemia, where increases corresponded
with hypo-perfusion induced by carotid clamping [53]
and correlated with greater stroke volumes in the emer-
gency department [42, 54]. However, the applicability of
this to the pre-hospital setting is currently unconfirmed.
There are many other candidate stroke diagnostic bio-
markers [55–65]. Inflammatory and anti-inflammatory
cytokines may have utility in diagnosing ischaemia [62–
65], but may not be useful in the hyper-acute phase due
to their late temporality after stroke onset [63–68]. Val-
idation is challenging due to the various clinical sub-
groups within the suspected stroke population, wide
ranges for normal values and latency of some of these
biomarkers, which would also limit their application in
hyper-acute diagnoses [57–61, 69]. As isolated bio-
markers do not appear to have adequate accuracy for a
definitive diagnosis, some evidence suggest a combin-
ation of biomarkers, reflecting various stroke-related
biological processes, may be optimal [59, 70–73].
A previous review of pre-hospital imaging technologies
for stroke diagnosis identified 10 devices in development
[74]. However, only two devices fulfilled our review cri-
teria of application during pre-hospital care. We identi-
fied a single-centre pre-hospital pilot study of an
infrared screening device, reporting moderate sensitivity
(~ 71%) and poor specificity (~ 40%) for differentiating
haemorrhagic stroke from ischaemia and mimics [24]
with diagnostic accuracy influenced by speed of the
moving ambulance [24]. No data are available on redir-
ection of patients to stroke-specific centres or patient
health outcomes following clinical use of the device.
Similar devices exist but have not been assessed in the
pre-hospital setting and some not yet in humans [75–
78]. ELECTRA-STROKE has yet to report on outcomes.
There are alternative electrophysiological devices with
intended application to the pre-hospital setting [79–82]
but clinical publications are lacking. Other potential pre-
hospital imaging technologies include Volumetric Inte-
gral Phase Shift Spectroscopy (VIPS) by Cerebrotech
Medical Systems, Inc., which has been evaluated in hos-
pital but not the pre-hospital setting. VIPS uses electro-
magnetic induction to detect ischaemic stroke (including
LVO) via hemispheric bioimpedence asymmetry. Evi-
dence of diagnostic accuracy is promising and a new
study is ongoing [83, 84]. Similar technologies exist but
at an earlier stage of development without pre-hospital
data reported [85–93] including magnetic particle im-
aging [94] ultrasonography [95–101] and accelerometery
[102, 103].
The European Academy of Neurology and European
Stroke Organization consensus statement for pre-
hospital management of stroke did not support routine
use of pre-hospital telemedicine for suspected stroke
[104]. However, we identified evidence from observa-
tional studies and one RCT [26–40] of the safety, feasi-
bility, and potential scalability of telemedicine, with
equivalent diagnostic accuracy to hospital-based clinical
diagnoses. Telestroke may expedite time-to-treatment by
attenuating hospital-based assessment, but studies to
date have shown little evidence of more efficient patient
redirection to stroke-specific centres and no impact on
health outcomes for specific population groups. There
are no trial reports of telestroke use to improve the
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delivery of thrombectomy. Although reported running
costs were relatively low, none of the studies reported
on the full range of costs required for implementation
(training, unit, operating and maintenance) which would
inform commissioning decisions. Nevertheless, increased
efficiency with telestroke (e.g., 13 min reductions in
door-to-needle time [34]) is congruent with mobile
stroke units [105], which also lack clear evidence of bet-
ter patient health outcomes [104]; telestroke technology
could be a significantly more cost-effective alternative in
systems which do not have specialists present in the am-
bulance [34]. In conjunction with clinician acceptability
for the majority of telestroke systems, the modest goal
(stratification) permits feasibility of implementing tele-
stroke technologies in the pre-hospital setting in the near
future; however, further studies are still required. Later-
stage barriers to implementation should also be addressed
in prior development work and monitored with qualitative
process evaluations alongside RCTs. One study evaluating
the acceptability/usability of a custom-built telestroke sys-
tem highlighted that EMS clinicians’ views on the poten-
tial efficacy of any new system is important for successful
deployment [40]. This underscores the need to engage
with relevant clinicians in the development and testing of
pre-hospital interventions.
In terms of quality, the included pre-hospital imaging
and biomarker studies were appropriately designed to as-
sess diagnostic accuracy, with reference standards as com-
parators. With exception of PRESSUB II [32, 33] and
Stroke Angel [29, 30], none of the included telemedicine
studies were adequately designed to formally assess diag-
nostic accuracy, although some confirmed the use of final
clinical diagnosis as a comparator [28, 31, 35]. As tele-
medicine cannot provide a definitive diagnosis, it is more
pertinent to assess scale reliability and reductions in time-
to-treatment via triage facilitation. The majority of tele-
medicine studies did assess time metrics and therefore ef-
ficacy [28–30, 32, 33, 35, 37–39], but were unblinded
observational reports and should be considered as service
evaluations rather than definitive evidence. Apart from
two telemedicine studies [32, 35], none of the studies re-
ported or planned to report cost-effectiveness. With ex-
ception of some large studies, the majority of studies were
small, single-centre studies and so lacked robust evidence.
The strengths of this review include a comprehensive
structured search strategy and independent assessment
at each stage of the review process. However, unpub-
lished data reporting on the efficacy of pre-hospital
stroke technology was not included. Additionally, many
emerging candidate technologies at earlier research
stages were omitted due to a lack of pre-hospital testing,
although the intention for most is to conduct pre-
hospital trials in the future. The results are limited by
the information provided in published reports about the
technology, clinical population and reference standard.
There were no high quality diagnostic accuracy studies.
As a decision support technology, telemedicine could act
as a precursor to hospital-based imaging and so will al-
ways have limited value when used in isolation. No study
combined telestroke with other technologies that may
enhance stratification.
In future, efficacy of technologies aiming to provide
definitive diagnoses (biomarkers and portable imaging)
should be first established in the hospital setting with a
clearly stated reference standard (brain imaging and spe-
cialist review) as a comparator. Using the most promis-
ing technologies, it would then be important to
undertake appropriate multi-centre studies comparing
standard EMS with a combination of direct stratification
(portable imaging and/or biomarkers) and facilitation
(telestroke) technologies, as well as additional validated
pre-hospital clinical assessment scales. This would estab-
lish: 1). efficacy of stroke diagnosis and stratification
across different pathways/service configurations; 2). add-
itional value over existing pre-notification systems; 3).
impact on service optimisation (particularly, minimisa-
tion of secondary transfer for thrombectomy); 4).
whether improved process measures (e.g. time metrics
and stratification) translate into clinically significant im-
provements in patient health and quality of life outcomes.
Once validated, impact on treatment decisions and patient
outcomes can be evaluated. Health economic evaluations
would also provide insights into cost-effectiveness to in-
form decision making by commissioners.
Conclusions
Although there is clear recognition of the potential value
for using emerging technology during the pre-hospital
diagnosis or stratification of suspected stroke, a lack of
high quality pre-hospital data on biomarkers and portable
imaging technologies suggests that further development
and validation in the pre-hospital setting is first required.
Evaluations of telestroke systems for diagnosis and stratifi-
cation of stroke indicate they are feasible and safe, but
they lack robust evidence for impact on service optimisa-
tion and cost-effective patient health outcomes. Multi-
centre diagnostic accuracy and clinical utility studies com-
bining these promising direct and adjunctive pre-hospital
diagnostic technologies are warranted to inform recom-
mendations on their use. Further development and valid-
ation of promising technologies has the potential to
revolutionise acute stroke diagnosis and stratification.
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